Open AccessPB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST‐MIND: A PHASE IB, OPEN‐LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Belada D.,
Kopeckova K.,
Bergua Burgues J. M.,
Stevens D.,
Nowakowski G. S.,
WaldronLynch M.,
Hadar N.,
Weirather J.,
Lässig C.,
Blair D.,
Dreyling M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851272.68157.fc
Subject(s) - medicine , chop , diffuse large b cell lymphoma , international prognostic index , vincristine , lenalidomide , rituximab , pharmacodynamics , prednisone , cyclophosphamide , lymphoma , gastroenterology , oncology , pharmacokinetics , chemotherapy , multiple myeloma